414 related articles for article (PubMed ID: 17050027)
1. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.
des Rieux A; Fievez V; Garinot M; Schneider YJ; Préat V
J Control Release; 2006 Nov; 116(1):1-27. PubMed ID: 17050027
[TBL] [Abstract][Full Text] [Related]
2. Targeted nanoparticles with novel non-peptidic ligands for oral delivery.
des Rieux A; Pourcelle V; Cani PD; Marchand-Brynaert J; Préat V
Adv Drug Deliv Rev; 2013 Jun; 65(6):833-44. PubMed ID: 23454185
[TBL] [Abstract][Full Text] [Related]
3. Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies.
Galindo-Rodriguez SA; Allemann E; Fessi H; Doelker E
Crit Rev Ther Drug Carrier Syst; 2005; 22(5):419-64. PubMed ID: 16313233
[TBL] [Abstract][Full Text] [Related]
4. Oral delivery of proteins by biodegradable nanoparticles.
Bakhru SH; Furtado S; Morello AP; Mathiowitz E
Adv Drug Deliv Rev; 2013 Jun; 65(6):811-21. PubMed ID: 23608641
[TBL] [Abstract][Full Text] [Related]
5. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs.
Cai Z; Wang Y; Zhu LJ; Liu ZQ
Curr Drug Metab; 2010 Feb; 11(2):197-207. PubMed ID: 20384585
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.
Soares AF; Carvalho Rde A; Veiga F
Nanomedicine (Lond); 2007 Apr; 2(2):183-202. PubMed ID: 17716120
[TBL] [Abstract][Full Text] [Related]
7. Cellular uptake and transcytosis of lipid-based nanoparticles across the intestinal barrier: Relevance for oral drug delivery.
Neves AR; Queiroz JF; Costa Lima SA; Figueiredo F; Fernandes R; Reis S
J Colloid Interface Sci; 2016 Feb; 463():258-65. PubMed ID: 26550783
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules.
Chen MC; Mi FL; Liao ZX; Hsiao CW; Sonaje K; Chung MF; Hsu LW; Sung HW
Adv Drug Deliv Rev; 2013 Jun; 65(6):865-79. PubMed ID: 23159541
[TBL] [Abstract][Full Text] [Related]
9. In vitro identification of targeting ligands of human M cells by phage display.
Fievez V; Plapied L; Plaideau C; Legendre D; des Rieux A; Pourcelle V; Freichels H; Jérôme C; Marchand J; Préat V; Schneider YJ
Int J Pharm; 2010 Jul; 394(1-2):35-42. PubMed ID: 20417702
[TBL] [Abstract][Full Text] [Related]
10. [Oral vaccination and vaccine-entrapped microparticle delivery system].
Li FQ; Fei YB; Su H; Hu JH
Yao Xue Xue Bao; 2007 Mar; 42(3):245-51. PubMed ID: 17520821
[TBL] [Abstract][Full Text] [Related]
11. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
Wang XQ; Zhang Q
Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229
[TBL] [Abstract][Full Text] [Related]
12. Oral vaccine delivery--new strategies and technologies.
Simerska P; Moyle PM; Olive C; Toth I
Curr Drug Deliv; 2009 Aug; 6(4):347-58. PubMed ID: 19534712
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of drugs to the gastrointestinal tract.
Lavelle EC
Crit Rev Ther Drug Carrier Syst; 2001; 18(4):341-86. PubMed ID: 11605896
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.
Beloqui A; Solinís MÁ; Gascón AR; del Pozo-Rodríguez A; des Rieux A; Préat V
J Control Release; 2013 Mar; 166(2):115-23. PubMed ID: 23266764
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation, protection, and delivery of bioactive proteins and peptides using nanoparticle and microparticle systems: A review.
McClements DJ
Adv Colloid Interface Sci; 2018 Mar; 253():1-22. PubMed ID: 29478671
[TBL] [Abstract][Full Text] [Related]
16. A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery.
Chen MC; Sonaje K; Chen KJ; Sung HW
Biomaterials; 2011 Dec; 32(36):9826-38. PubMed ID: 21925726
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles and microparticles for drug and vaccine delivery.
Kreuter J
J Anat; 1996 Dec; 189 ( Pt 3)(Pt 3):503-5. PubMed ID: 8982823
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
19. Targeting of gastrointestinal tract for amended delivery of protein/peptide therapeutics: strategies and industrial perspectives.
Pawar VK; Meher JG; Singh Y; Chaurasia M; Surendar Reddy B; Chourasia MK
J Control Release; 2014 Dec; 196():168-83. PubMed ID: 25305562
[TBL] [Abstract][Full Text] [Related]
20. The intestinal uptake of particles and the implications for drug and antigen delivery.
O'Hagan DT
J Anat; 1996 Dec; 189 ( Pt 3)(Pt 3):477-82. PubMed ID: 8982819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
